Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Competitive Insights
Chapter 3 Monkeypox Vaccine and Treatment Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market
3.2 Market Dynamics
3.2.1 Market drivers analysis
3.2.1.1 Increase in prevalence of monkeypox infection
3.2.1.2 Government initiatives to combat outbreak of monkeypox
3.2.2 Market restraint analysis
3.2.2.1 Side effects associated with the vaccine and treatment
3.3 Penetration & Growth Prospect Mapping
3.4 Monkeypox Vaccine and Treatment: Market Analysis Tools
3.4.1 Industry analysis – Porter’s
3.4.2 PESTLE analysis
3.5 Regulatory Framework
3.6 Pricing Analysis
Chapter 4 Monkeypox Vaccine and Treatment Market Segment Analysis, By Product, 2022 – 2030 (USD Million)
4.1 Definition and Scope
4.2 Product Market Share Analysis, 2022 & 2030
4.3 Segment Dashboard
4.4 Global Monkeypox Vaccine and Treatment Market, by Product, 2022 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2022 to 2030
4.5.1 Vaccine
4.5.1.1 Vaccine market estimates and forecasts, 2022 – 2030 (USD Million)
4.5.1.1.1 JYNNEOS/Imvanex
4.5.1.1.1.1 JYNNEOS/Imvanex market estimates and forecasts, 2022 – 2030 (USD Million)
4.5.1.1.2 Smallpox Vaccine
4.5.1.1.2.1 Smallpox vaccine market estimates and forecasts, 2022 – 2030 (USD Million)
4.5.1.1.3 Others
4.5.1.1.3.1 Others market estimates and forecasts, 2022 – 2030 (USD Million)
4.5.2 Drugs
4.5.2.1 Drugs market estimates and forecasts, 2022 – 2030 (USD Million)
4.5.2.1.1 Tecovirimat
4.5.2.1.1.1 Tecovirimat market estimates and forecasts, 2022 – 2030 (USD Million)
4.5.2.1.2 Brincidofovir
4.5.2.1.2.1 Brincidofovir market estimates and forecasts, 2022 – 2030 (USD Million)
4.5.2.1.3 Cidofovir
4.5.2.1.3.1 Cidofovir market estimates and forecasts, 2022 – 2030 (USD Million)
4.5.2.1.4 Others
4.5.2.1.4.1 Others market estimates and forecasts, 2022 – 2030 (USD Million)
4.5.3 Vaccinia Immune Globulin (VIG)
4.5.3.1 Vaccinia Immune Globulin (VIG)market estimates and forecasts, 2022 – 2030 (USD Million)
Chapter 5 Monkeypox Vaccine and Treatment Market Segment Analysis, By Route of Administration2022 – 2030 (USD Million)
5.1 Definition and Scope
5.2 Route of Administration Market Share Analysis, 2022 & 2030
5.3 Segment Dashboard
5.4 Global Monkeypox Vaccine and Treatment Market, by Route of Administration, 2022 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2022 to 2030
5.5.1 Oral
5.5.1.1 Oral market estimates and forecasts, 2022 – 2030 (USD Million)
5.5.2 Injectable
5.5.2.1 Injectable market estimates and forecasts, 2022 – 2030 (USD Million)
Chapter 6 Monkeypox Vaccine and Treatment Market Segment Analysis, By Gender, 2022 – 2030 (USD Million)
6.1 Definition and Scope
6.2 Gender Market Share Analysis, 2022 & 2030
6.3 Segment Dashboard
6.4 Global Monkeypox Vaccine and Treatment Market, by Gender, 2022 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2022 to 2030
6.5.1 Male
6.5.1.1 Male market estimates and forecasts, 2022 – 2030 (USD Million)
6.5.2 Female
6.5.2.1 Female market estimates and forecasts, 2022 – 2030 (USD Million)
6.5.3 Others
6.5.3.1 Others market estimates and forecasts, 2022 – 2030 (USD Million)
Chapter 7 Monkeypox Vaccine and Treatment Market Segment Analysis, By End-use, 2022 – 2030 (USD Million)
7.1 Definition and Scope
7.2 End-use Market Share Analysis, 2022 & 2030
7.3 Segment Dashboard
7.4 Global Monkeypox Vaccine and Treatment Market, by End-use, 2022 to 2030
7.5 Market Size & Forecasts and Trend Analyses, 2022 to 2030
7.5.1 Hospitals
7.5.1.1 Hospitals market estimates and forecasts, 2022 – 2030 (USD Million)
7.5.2 Specialty Clinics
7.5.2.1 Specialty clinics market estimates and forecasts, 2022 – 2030 (USD Million)
7.5.3 Others
7.5.3.1 Others market estimates and forecasts, 2022 – 2030 (USD Million)
Chapter 8 Monkeypox Vaccine and Treatment Market Segment Analysis, By Region, 2022 – 2030 (USD Million)
8.1 Definition & Scope
8.2 Regional Market Share Analysis, 2022 & 2030
8.3 Regional Market Dashboard
8.4 Regional Market Snapshot
8.5 SWOT Analysis
8.5.1 North America
8.5.2 Europe
8.5.3 Asia Pacific
8.5.4 Latin America
8.5.5 Middle East and Africa
8.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
8.6.1 North America
8.6.1.1 North America market estimates and forecast, 2022-2030 (USD Million)
8.6.1.2 U.S.
8.6.1.2.1 U.S. monkeypox vaccine and treatment market estimates and forecasts, 2022 – 2030 (USD Million)
8.6.1.3 Canada
8.6.1.3.1 Canada monkeypox vaccine and treatment market estimates and forecasts, 2022 – 2030 (USD Million)
8.6.2 Europe
8.6.2.1 Europe monkeypox vaccine and treatment market estimates and forecasts, 2022 – 2030 (USD Million)
8.6.2.2 U.K.
8.6.2.2.1 U.K. monkeypox vaccine and treatment market estimates and forecasts, 2022 – 2030 (USD Million)
8.6.2.3 Germany
8.6.2.3.1 Germany monkeypox vaccine and treatment market estimates and forecasts, 2022 – 2030 (USD Million)
8.6.2.4 Spain
8.6.2.4.1 Spain monkeypox vaccine and treatment market estimates and forecasts, 2022 – 2030 (USD Million)
8.6.2.5 France
8.6.2.5.1 France monkeypox vaccine and treatment market estimates and forecasts, 2022 – 2030 (USD Million)
8.6.2.6 Italy
8.6.2.6.1 Italy monkeypox vaccine and treatment market estimates and forecasts, 2022 – 2030 (USD Million)
8.6.3 Asia Pacific
8.6.3.1 Asia Pacific monkeypox vaccine and treatment market estimates and forecasts, 2022 – 2030 (USD Million)
8.6.3.2 Japan
8.6.3.2.1 Japan monkeypox vaccine and treatment market estimates and forecasts, 2022 – 2030 (USD Million)
8.6.3.3 China
8.6.3.3.1 China monkeypox vaccine and treatment market estimates and forecasts, 2022 – 2030 (USD Million)
8.6.3.4 India
8.6.3.4.1 India monkeypox vaccine and treatment market estimates and forecasts, 2022 – 2030 (USD Million)
8.6.3.5 South Korea
8.6.3.5.1 South Korea monkeypox vaccine and treatment market estimates and forecasts, 2022 – 2030 (USD Million)
8.6.3.6 Australia
8.6.3.6.1 Australia monkeypox vaccine and treatment market estimates and forecasts, 2022 – 2030 (USD Million)
8.6.4 Latin America
8.6.4.1 Latin America monkeypox vaccine and treatment market estimates and forecasts, 2022 – 2030 (USD Million)
8.6.4.2 Brazil
8.6.4.2.1 Brazil monkeypox vaccine and treatment market estimates and forecasts, 2022 – 2030 (USD Million)
8.6.4.3 Mexico
8.6.4.3.1Mexico monkeypox vaccine and treatment market estimates and forecasts, 2022 – 2030 (USD Million)
8.6.4.4 Argentina
8.6.4.4.1 Argentina monkeypox vaccine and treatment market estimates and forecasts, 2022 – 2030 (USD Million)
8.6.5 MEA
8.6.5.1 MEA monkeypox vaccine and treatment market estimates and forecasts, 2022 – 2030 (USD Million)
8.6.5.2 South Africa
8.6.5.2.1 South Africa monkeypox vaccine and treatment market estimates and forecasts, 2022 – 2030 (USD Million)
8.6.5.3 Saudi Arabia
8.6.5.3.1 Saudi Arabia monkeypox vaccine and treatment market estimates and forecasts, 2022 – 2030 (USD Million)
8.6.5.4 UAE
8.6.5.4.1 UAE monkeypox vaccine and treatment market estimates and forecasts, 2022 – 2030 (USD Million)
Chapter 9 Monkeypox Vaccine and Treatment Market – Competitive Analysis
9.1 Recent Developments & Impact Analysis, by Key Market Participants
9.1.1 Ansoff matrix
9.1.2 Heat map analysis
9.1.3 Major Deals and Strategic Alliances Analysis
9.1.3.1 Joint Ventures
9.1.3.2 Licensing Agreements
9.1.3.3 Product Launches
9.1.3.4 Conferences and Campaigns
9.2 Company Categorization
9.2.1 Innovators
9.2.2 Market Leaders
9.3 Vendor Landscape
9.3.1 List of key distributors and channel partners
9.3.2 Key customers
9.4 Public Companies
9.4.1 Competitive Dashboard Analysis
9.4.1.1 Market Differentiators
9.5 Private Companies
9.5.1 List of key emerging companies
9.6 Company Profiles
9.6.1 Bavarian Nordic
9.6.1.1 Company overview
9.6.1.2 Financial performance
9.6.1.3 Product benchmarking
9.6.1.4 Strategic Initiatives
9.6.2 SIGA Technologies
9.6.2.1 Company overview
9.6.2.2 Financial performance
9.6.2.3 Product benchmarking
9.6.2.4 Strategic Initiatives
9.6.3 Chimerix
9.6.3.1 Company overview
9.6.3.2 Financial performance
9.6.3.3 Product benchmarking
9.6.3.4 Strategic Initiatives
9.6.4 EMERGENT
9.6.4.1 Company overview
9.6.4.2 Financial performance
9.6.4.3 Product benchmarking
9.6.4.4 Strategic Initiatives
9.6.5 Gilead Sciences, Inc.
9.6.5.1 Company overview
9.6.5.2 Financial performance
9.6.5.3 Product benchmarking
9.6.5.4 Strategic Initiatives